EPISODE · Jun 24, 2026 · 1 MIN
GLP-1s May Reduce Cancer Progression
from CareTalk: Healthcare. Unfiltered. · host CareTalk: Healthcare. Unfiltered.
Send us Fan MailGLP-1 drugs were designed for weight loss. Now they may be showing up in cancer research in a way nobody expected.In this clip from our episode “The Business & Science Behind the GLP-1 Boom”, hosts David E. Williams and John Driscoll break down what the 2026 ASCO annual meeting revealed about GLP-1s and their potential to reduce cancer progression in lung, breast, colorectal, and liver cancer.Listen to the full episode here🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.
Embed this episode
What this episode covers
Send us Fan Mail GLP-1 drugs were designed for weight loss. Now they may be showing up in cancer research in a way nobody expected. In this clip from our episode “The Business & Science Behind the GLP-1 Boom”, hosts David E. Williams and John Driscoll break down what the 2026 ASCO annual meeting revealed about GLP-1s and their potential to reduce cancer progression in lung, breast, colorectal, and liver cancer. Listen to the full episode here 🎙️⚕️ABOUT CARETALK CareTalk is a weekly podc...
NOW PLAYING
GLP-1s May Reduce Cancer Progression
No transcript for this episode yet
Similar Episodes
No similar episodes found.